Martin Joseph Joyce - Net Worth and Insider Trading

Martin Joseph Joyce Net Worth

The estimated net worth of Martin Joseph Joyce is at least $99,942 dollars as of 2024-05-16. Martin Joseph Joyce is the Director of Aldeyra Therapeutics Inc and owns about 23,967 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $99,942. Details can be seen in Martin Joseph Joyce's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martin Joseph Joyce has not made any transactions after 2022-06-23 and currently still holds the listed stock(s).

Transaction Summary of Martin Joseph Joyce

To

Martin Joseph Joyce Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martin Joseph Joyce owns 2 companies in total, including Aldeyra Therapeutics Inc (ALDX) , and Caliber Imaging & Diagnostics Inc (LCDX) .

Click here to see the complete history of Martin Joseph Joyce’s form 4 insider trades.

Insider Ownership Summary of Martin Joseph Joyce

Ticker Comapny Transaction Date Type of Owner
ALDX Aldeyra Therapeutics Inc 2022-06-23 director
LCDX Caliber Imaging & Diagnostics Inc 2011-12-27 Chief Financial Officer

Martin Joseph Joyce Latest Holdings Summary

Martin Joseph Joyce currently owns a total of 1 stock. Martin Joseph Joyce owns 23,967 shares of Aldeyra Therapeutics Inc (ALDX) as of June 23, 2022, with a value of $99,942.

Latest Holdings of Martin Joseph Joyce

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDX Aldeyra Therapeutics Inc 2022-06-23 23,967 4.17 99,942

Holding Weightings of Martin Joseph Joyce


Martin Joseph Joyce Form 4 Trading Tracker

According to the SEC Form 4 filings, Martin Joseph Joyce has made a total of 2 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 4,323 shares on June 23, 2022, which cost Martin Joseph Joyce around $15,044.

Insider Trading History of Martin Joseph Joyce

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martin Joseph Joyce Trading Performance

GuruFocus tracks the stock performance after each of Martin Joseph Joyce's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Joseph Joyce is 9.91%. GuruFocus also compares Martin Joseph Joyce's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Joseph Joyce within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martin Joseph Joyce's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martin Joseph Joyce

Average Return

Average return per transaction

Outperforming Transactions

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.57
Relative Return to S&P 500(%) 11.16

Martin Joseph Joyce Ownership Network

Ownership Network List of Martin Joseph Joyce

No Data

Ownership Network Relation of Martin Joseph Joyce


Martin Joseph Joyce Owned Company Details

What does Aldeyra Therapeutics Inc do?

Who are the key executives at Aldeyra Therapeutics Inc?

Martin Joseph Joyce is the director of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Development Officer Stephen Machatha , and director & President and CEO Todd C Brady .

Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary

Over the past 18 months, Martin Joseph Joyce made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 41,305 shares made by Stephen Machatha , and a net sale of 26,402 shares made by Bruce Greenberg .

In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aldeyra Therapeutics Inc Insider Transactions

No Available Data

Martin Joseph Joyce Mailing Address

Above is the net worth, insider trading, and ownership report for Martin Joseph Joyce. You might contact Martin Joseph Joyce via mailing address: 1050 Hingham Street, Rockland Ma 02370.

Discussions on Martin Joseph Joyce

No discussions yet.